Mizuho raised the firm’s price target on Envista (NVST) to $19 from $18 and keeps an Underperform rating on the shares. Envista continued its trend of modest market share gains in Q3 from what the firm believe is a better-positioned product portfolio than broad dental peers, says the analyst, who raised the firm’s 2025 and 2026 EPS estimates to reflect the market share gains.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NVST:
- Envista Holdings’ Earnings Call Highlights Strong Growth
- Envista price target raised to $27 from $25 at Baird
- Envista Holdings: Strong Q3 Performance and Upward Guidance, Yet Valuation Concerns Justify Hold Rating
- Envista Holdings: Positive Growth Trends and Margin Improvements Drive Buy Rating
- Envista Holdings Reports Strong Q3 2025 Results